Smith, J P <br/><br/>
Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts.  [electronic resource] 

 -  Anti-cancer drugs  Dec 1995 
 - 717-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/00001813-199512000-00002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Delayed-Action Preparations<br/>Drug Screening Assays, Antitumor<br/>Fluorouracil--pharmacokinetics<br/>Gels<br/>Humans<br/>Injections, Intraperitoneal<br/>Male<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Pancreatic Neoplasms--drug therapy<br/>Rats<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured